Trial Profile
Differential effects of risedronic acid on bone microarchitecture in women in early menopause or in older postmenopausal women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2013
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 13 Nov 2013 New trial record
- 08 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.